Shares of Bioventix PLC (LON:BVXP - Get Free Report) passed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of GBX 3,184.98 ($42.79) and traded as low as GBX 2,460 ($33.05). Bioventix shares last traded at GBX 2,493 ($33.49), with a volume of 18,396 shares.
Bioventix Price Performance
The firm has a market capitalization of £136.04 million, a P/E ratio of 16.80 and a beta of 0.35. The company's 50 day moving average price is GBX 2,665.01 and its 200 day moving average price is GBX 3,153.14.
Bioventix (LON:BVXP - Get Free Report) last announced its quarterly earnings data on Monday, March 31st. The biotechnology company reported GBX 72.27 ($0.97) EPS for the quarter. Bioventix had a net margin of 59.51% and a return on equity of 69.09%. On average, research analysts anticipate that Bioventix PLC will post 166.3066955 EPS for the current fiscal year.
Bioventix Cuts Dividend
The company also recently declared a dividend, which was paid on Friday, April 25th. Shareholders of record on Thursday, April 10th were given a dividend of GBX 70 ($0.94) per share. This represents a yield of 2.95%. The ex-dividend date was Thursday, April 10th. Bioventix's dividend payout ratio (DPR) is currently 102.19%.
Insider Activity at Bioventix
In other Bioventix news, insider Bruce Hiscock acquired 31 shares of the business's stock in a transaction on Monday, April 28th. The stock was purchased at an average price of GBX 2,632 ($35.36) per share, with a total value of £815.92 ($1,096.22). 8.02% of the stock is owned by company insiders.
Bioventix Company Profile
(
Get Free Report)
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants.
Read More
Before you consider Bioventix, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bioventix wasn't on the list.
While Bioventix currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
